Evercore ISI Lowers MetLife Price Target to $95, Maintains 'In Line' Rating

Evercore ISI has adjusted its price target for insurance giant MetLife (MET) to $95, down from the previous $97. The analyst firm simultaneously maintained its "In Line" rating on MetLife's stock, signaling its view that the shares are expected to perform in line with the broader market. This revision reflects a re-evaluation by Evercore ISI, likely influenced by recent financial presentations and other analyst revisions concerning the company's outlook. While indicating a slightly negative sentiment, this minor downward adjustment by a single analyst is generally not expected to trigger significant market movement for MetLife shares. Investors typically monitor such adjustments as part of a broader analytical landscape.